Brazil threatens to break patent on AIDS drugs

There are no reviewed versions of this page, so it may not have been checked for adherence to standards.

Wednesday, July 6, 2005

Brazil is threatening to break the patent of US-based Abbott Laboratories as it pushes ahead with its programme to supply its people with free AIDS drugs.

Brazil has given Abbott a deadline of July 7 to cut the prices of its drug Kaletra or a Brazilian company will begin cloning it. This move would test recent World Trade Organization concessions allowing poor countries to produce generic drugs for local health emergencies.

Abbott has said that Brazil's demand goes "against the spirit" of the WTO agreement, since it has the ninth largest economy in the world, and that this could damage future research for improved treatments.

Previous programmes have been negotiated between companies and governments to produce generic versions of AIDS drugs, but this is the first time a country has threatened to use powers negotiated at the WTO by producing the drug without the cooperation of the patent holder.

Several campaign groups are supporting the move, hoping that other developing countries will be able to take the lead of Brazil and produce generic drugs for their own populations. Michael Bailey, a senior policy adviser for Oxfam International, said: "The impact of breaking the patent would be enormous. If a major country such as Brazil goes through with this, not only will it help ensure sustainability of their excellent treatment programme, it will set a hugely important precedent for other countries."

The US Chamber of Commerce has issued a statement urging Brazil to reconsider and suggesting that the move could create a rift between the countries. Thomas Donohue, Chamber President and CEO said: "Brazil’s threat to strip patent rights from a U.S. company should concern all investors and every business around the world because of the precedent it sets for the treatment of intellectual property."

Sources

Tim Kingston. "Local activists back Brazil's demand that US companies allow the creation of cheap, generic AIDS drugs" — San Francisco Bay Guardian, July 6, 2005
"Brazil may 'win Aids struggle'" — News24, July 5, 2005
Philip Thornton. "Abbott Laborotories faced with anti-Aids drug dilemma" — Independent, July 4, 2005
US Chamber of Commerce. "Statement" — ABC News, July 4, 2005
"US clears two generic AIDS drugs for global plan" — ABC News, June 20, 2005

Share this:

The text of this article has been released into the public domain. In the event that this is not legally possible, this article may be used for any purpose, without any condition, unless such conditions are required by law. This applies worldwide. Copyright terms on images, however, may vary, so please check individual image pages prior to duplication.
Please note that this only applies to Wikinews content created prior to September 25, 2005. All content created after that date is released under a Creative Commons license which is mentioned at the bottom of each article. This is currently the Creative Commons Attribution 2.5 License.

This page is archived, and is no longer publicly editable.

Articles presented on Wikinews reflect the specific time at which they were written and published, and do not attempt to encompass events or knowledge which occur or become known after their publication.

Got a correction? Add the template {{editprotected}} to the talk page along with your corrections, and it will be brought to the attention of the administrators.

Please note that due to our archival policy, we will not alter or update the content of articles that are archived, but will only accept requests to make grammatical and formatting corrections.

Note that some listed sources or external links may no longer be available online due to age.